Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis

Journal of Infection and Chemotherapy

Volumn 17, Issue 2, 2011, Pages 268-271

  Kaneko, Hiroto ^a   Shimura, Kazuho ^a   Nishida, Koichi ^a   Fujiwara, Yasunori ^b   Matsumoto, Yousuke ^c   Kuroda, Junya ^c   Horiike, Shigeo ^c   Yokota, Shouhei ^c   Ohkawara, Yasuo ^a   Taniwaki, Masafumi ^c  

^a Aiseikai Yamashina Hospital   (Japan)

^b Fujiwara Urological Clinic   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Iron deficiency anemia; Parvovirus B19; Pure red cell aplasia; Rituximab

Indexed keywords

ANTIPYRETIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEMOGLOBIN; IMMUNOGLOBULIN M ANTIBODY; PREDNISOLONE; RITUXIMAB; VINCRISTINE; VIRUS DNA;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; DISEASE SEVERITY; DNA DETERMINATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; ERYTHROID PRECURSOR CELL; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HUMAN PARVOVIRUS B19; HUMAN TISSUE; IRON DEFICIENCY ANEMIA; LEUKOPENIA; LYMPHOCYTOMA; MICROCYTIC ANEMIA; PARVOVIRUS INFECTION; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PURE RED CELL ANEMIA; RETICULOCYTE COUNT; VIRUS DETECTION; VIRUS LOAD;

EID: 79955899588     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0106-0     Document Type: Article

References (22)

1. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol. 1988;25:159-72.
2. Rappaport ES, Quick G, Ransom D, Helbert B, Frankel LS. Aplastic crisis in occult hereditary spherocytosis caused by human parvovirus B19 (HPV B19). South Med. 1989;82:247-51. (Pubitemid 19189272)
3. Lefrere JJ, Bourgeois H. Human parvovirus associated with erythroblastopenia in iron deficiency anaemia. J Clin Pathol. 1986;39:1277-8.
4. Kojima S, Matsuyama K, Ishii E. High serum iron in human parvovirus-induced aplastic crisis in iron deficiency anemia. Acta Haematol. 1988;80:171-2. (Pubitemid 19003835)
5. Negami T, Ohta M, Okuda K, Shimizu S. Parvovirus B19- induced aplastic crisis in a patient with iron deficiency anemia. Jpn J Clin Hematol. 1994;35:670-5.
6. Tarantino MD, Shahidi NT. Parvovirus B19-induced red blood cell aplasia complicating iron-deficiency anemia. Clin Pediatr. 1995;34:108-9.
7. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood. 2000;96:1184-6. (Pubitemid 30616893)
8. Song KW, Mollee P, Patterson B, Rrien W, Crump M. Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. Br J Haematol. 2002;119:125-7. (Pubitemid 35176510)
9. Isobe Y, Sugimoto K, Shiraki Y, Nishitani M, Koike K, Oshimi K. Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy. Am J Hematol. 2004;77:370-3. (Pubitemid 39578319)
10. Young N, Harrison M, Moore J, Mortimer P, Humphries RK. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest. 1984;74:2024-32. (Pubitemid 15197345)
11. Klepfish A, Rachmilevitch E, Schattner A. Parvovirus B19 reactivation presenting as neutropenia after rituximab treatment. Eur J Intern Med. 2006;17:505-7. (Pubitemid 44708740)
12. Chikkappa G, Zarrabi MH, Tsan MF. Pure red cell aplasia in patients with chronic lymphocytic leukemia. Medicine. 1986;65:339-51. (Pubitemid 17180483)
13. Zecca M, Stefano PD, Nobili B, Locatelli F. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood. 2001;97:3995-7.
14. Ghazal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood. 2002;99:1092-4. (Pubitemid 34525578)
15. Carloss HW, Saab GA, Tavassoli M. Pure red cell aplasia and lymphoma. JAMA. 1979;242:67-8. (Pubitemid 9232184)
16. Koduri PR, Kumapley R, Valladares J, Teter C. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin - a report of eight patients. Am J Hematol. 1999;61:16-20. (Pubitemid 29218172)
17. Herbert KE, Prince HM, Westerman DA. Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemutuzumab. Blood. 2003;101:1654. (Pubitemid 36182548)
18. Suzuki T, Saito S, Hirabayashi Y, Harigae H, Ishii T, Kodera T, et al. Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus. Intern Med. 2003;42:538-40. (Pubitemid 36926821)
19. Ki CS, Kim IS, Kim JW, Lee NY, Kim SH, Lee KW, et al. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant. 2005;19:751-5. (Pubitemid 41748727)
20. El-Mahallawy HA, Mansour T, El-Din SE, Hafez M, Abdel-Latif S. Parvovirus B19 infection as a cause of anemia in pediatric acute lymphoblastic leukemia patients during maintenance chemotherapy. J Pediatr Hematol Oncol. 2004;26:403-6. (Pubitemid 39025250)
21. Schiavotto C, Ruggeri M, Rodeghierof F. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica. 1993;78(Suppl 2):35-40.
22. Hayakawa F, Imada K, Towatari M, Saito H. Life-threatening human parvovirus B19 infection transmitted by intravenous immune globulin. Br J Haematol. 2002;118:1187-9. (Pubitemid 35025990)